Press Release Details

Quest Diagnostics Commences


TETERBORO, NEW JERSEY, JANUARY 14, 1997 -- Quest Diagnostics Incorporated (NYSE:DGX), formerly Corning Clinical Laboratories Inc., today announced the commencement of "regular-way" trading of its common stock on the New York Stock Exchange.

The Company's common stock will trade under the ticker symbol DGX. Quest Diagnostics was spun-off by Corning Incorporated on December 31, 1996.

Quest Diagnostics is one of the leading clinical testing laboratories in the country. With 17 regional labs and 14 smaller branch labs across the U.S. and a branch lab in Mexico City, Quest Diagnostics processes and provides data on 60 million requisitions for specimens annually. The wide variety of tests it performs on human tissue and fluids help doctors and hospitals diagnose, treat and monitor diseases and disease states. Quest Diagnostics' research arm, Nichols Institute, specializes in "esoteric testing" using genetic screening and other advanced technologies.